Bericht
The World Health Organization reforms in the time of COVID-19
During its 70-year history, the World Health Organization (WHO) has undergone various reforms led by several Directors-General, including Halfdan Mahler at the Almaty Conference on primary health care in 1978, Gro Harlem Brundtland with her “reach out to the private sector” in 1998, and Margaret Chan with her unfinished debate on the role of “non-state actors” in 2012. The organization’s fragility is once again being highlighted, as the COVID-19 pandemic has revealed that WHO does not have the legal instruments and mechanisms necessary to enforce its standards and guidelines, and that its funding is not sustainable and adequate to respond to the challenge. This paper seeks to identify the main problems faced by WHO and the necessary measures that a reform of the organization would have to take.
- Sprache
-
Englisch
- Erschienen in
-
Series: Research Paper ; No. 121
- Klassifikation
-
Sozialwissenschaften, Soziologie, Anthropologie
- Thema
-
Article 19 WHO Constitution
Coronavirus
COVID-19
France
Germany
Global Health
Health
International Health Regulations (IHR)
Non-Paper on Strengthening WHO
Pandemic
Public Health
WHO
WHO Executive Board (EB)
WHO Reform
World Health Assembly (WHA)
World Health Organization
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Velásquez, Germán
- Ereignis
-
Veröffentlichung
- (wer)
-
South Centre
- (wo)
-
Geneva
- (wann)
-
2020
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Bericht
Beteiligte
- Velásquez, Germán
- South Centre
Entstanden
- 2020
Ähnliche Objekte (12)
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Analysis of the Doha negotiations and the functioning of the World Trade Organization
Access to medicines and intellectual property: The contribution of the World Health Organization
Leading and coordinating global health: Strengthening the World Health Organization
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Can negotiations at the World Health Organization lead to a just framework for the prevention, preparedness and response to pandemics as global public goods?
Analysis of COVID-related patents for antibodies and vaccines
Equitable access to COVID-19 related health technologies: A global priority
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Del SIDA al COVID-19: La OMS ante las crisis sanitarias globales
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Analysis of the Doha negotiations and the functioning of the World Trade Organization
Access to medicines and intellectual property: The contribution of the World Health Organization
Leading and coordinating global health: Strengthening the World Health Organization
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Can negotiations at the World Health Organization lead to a just framework for the prevention, preparedness and response to pandemics as global public goods?
Analysis of COVID-related patents for antibodies and vaccines
Equitable access to COVID-19 related health technologies: A global priority
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Del SIDA al COVID-19: La OMS ante las crisis sanitarias globales
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Analysis of the Doha negotiations and the functioning of the World Trade Organization
Access to medicines and intellectual property: The contribution of the World Health Organization
Leading and coordinating global health: Strengthening the World Health Organization
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Can negotiations at the World Health Organization lead to a just framework for the prevention, preparedness and response to pandemics as global public goods?
Analysis of COVID-related patents for antibodies and vaccines
Equitable access to COVID-19 related health technologies: A global priority
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19